On May 12th, SINOTHERAPEUTICS stated on the interactive platform that since the beginning of this year, the U.S. market has faced uncertainties due to bilateral tariff adjustments, which may adversely affect the company's product sales in the U.S. market. However, as of the first quarter of 2025, there have been no significant shelf adjustments in the company's sales in the U.S. market; at the same time, the company has actively expanded into other international markets in recent years, and has reached product cooperation agreements with relevant distributors in countries or regions such as Canada, Australia, Israel, Southeast Asia, Gulf countries, and Central and South America, with some products already approved for sale in the respective markets, which will have a positive impact on the company's performance
